marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 02-14-2024
Amgen Balance Sheet 2011-2024 | AMGN
Annual Balance Sheet Amgen
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
52.3 B | 29.9 B | 25.4 B | 26.8 B | 23.9 B | 27 B | 31.5 B | 31.4 B | 27.4 B | 27 B | 28.3 B | 23.3 B | 14.5 B |
Long Term Debt |
63.2 B | 37.4 B | 33.2 B | 32.9 B | 27 B | 29.5 B | 34.2 B | 30.2 B | 29.3 B | 30.2 B | 29.6 B | 24 B | 21.3 B |
Long Term Debt Current |
119 M | 156 M | 145 M | 153 M | 140 M | 4.42 B | 1.15 B | 4.4 B | 2.25 B | 500 M | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 37.2 B | 40.4 B | 45.7 B | 36.5 B | 34.8 B | 36.2 B | 36.1 B | 27 B | 24.1 B |
Total Current Liabilities |
18.4 B | 15.7 B | 12.2 B | 11.7 B | 12.8 B | 13.5 B | 9.02 B | 11.2 B | 8.66 B | 7.01 B | 7.95 B | 8.19 B | 5.75 B |
Total Liabilities |
- | - | - | - | 50 B | 53.9 B | 54.7 B | 47.8 B | 43.5 B | 43.2 B | 44 B | 35.2 B | 29.8 B |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-26.5 B | -28.6 B | -24.6 B | -21.4 B | -21.3 B | -18 B | -5.07 B | -438 M | -2.09 B | -4.62 B | -7.63 B | -10.4 B | -8.92 B |
Total Assets |
97.2 B | 65.1 B | 61.2 B | 62.9 B | 59.7 B | 66.4 B | 80 B | 77.6 B | 71.6 B | 69 B | 66.1 B | 54.3 B | 48.9 B |
Cash and Cash Equivalents |
10.9 B | 7.63 B | 7.99 B | 6.27 B | 6.04 B | 6.94 B | 3.8 B | 3.24 B | 4.14 B | 3.73 B | 3.8 B | 3.26 B | 6.95 B |
Book Value |
97.2 B | 65.1 B | 61.2 B | 62.9 B | 9.67 B | 12.5 B | 25.2 B | 29.9 B | 28.1 B | 25.8 B | 22.1 B | 19.1 B | 19 B |
Total Shareholders Equity |
6.23 B | 3.66 B | 6.7 B | 9.41 B | 9.67 B | 12.5 B | 25.2 B | 29.9 B | 28.1 B | 25.8 B | 22.1 B | 19.1 B | 19 B |
All numbers in USD currency
Quarterly Balance Sheet Amgen
| 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
59 B | 37.4 B | - | - | 36 B | 33.2 B | 33.3 B | 28.5 B | 31.1 B | 32.9 B | 32.9 B | 32.9 B | 32.9 B | 27 B | 27 B | 27 B | 27 B | 29.5 B | 29.5 B | 29.5 B | 29.5 B | 34.2 B | 34.2 B | 34.2 B | 34.2 B | 30.2 B | 30.2 B | 30.2 B | 30.2 B | 29.2 B | 29.2 B | 29.2 B | 29.2 B | 30.1 B | 30.2 B | 30.2 B | 30.2 B | 29.6 B | 29.6 B | 29.6 B | 32.1 B | 26.5 B | 26.5 B | 26.5 B | 26.5 B | 21.4 B | 21.4 B | 13.8 B | 10.8 B |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-25 B | -28.6 B | - | - | -29.6 B | -24.6 B | -23 B | -22.8 B | -21.6 B | -21.4 B | -21.4 B | -21.4 B | -21.4 B | -21.3 B | -21.3 B | -21.3 B | -21.3 B | -18 B | -18 B | -18 B | -18 B | -5.07 B | -5.07 B | -5.07 B | -5.07 B | -438 M | -438 M | -438 M | -438 M | -2.09 B | -2.09 B | -2.09 B | -2.09 B | -4.62 B | -4.62 B | -4.62 B | -4.62 B | -7.63 B | -7.63 B | -7.63 B | -7.63 B | -10.4 B | -10.4 B | -10.4 B | -10.4 B | -8.92 B | -8.92 B | -8.92 B | -8.92 B |
Total Assets |
90.5 B | 65.1 B | - | - | 59.2 B | 61.2 B | 65 B | 59.8 B | 62.5 B | 62.9 B | 62.9 B | 62.9 B | 62.9 B | 59.7 B | 59.7 B | 59.7 B | 59.7 B | 66.4 B | 66.4 B | 66.4 B | 66.4 B | 80 B | 80 B | 80 B | 80 B | 77.6 B | 77.6 B | 77.6 B | 77.6 B | 71.4 B | 71.4 B | 71.4 B | 71.4 B | 68.9 B | 69 B | 69 B | 69 B | 66.1 B | 66.1 B | 66.1 B | 66.1 B | 54.3 B | 54.3 B | 54.3 B | 54.3 B | 48.9 B | 48.9 B | 48.9 B | 48.9 B |
Cash and Cash Equivalents |
34.7 B | 7.63 B | 9.5 B | - | 6.53 B | 7.99 B | 12 B | 6.63 B | 6.11 B | 6.27 B | 6.27 B | 6.27 B | 6.27 B | 6.04 B | 6.04 B | 6.04 B | 6.04 B | 6.94 B | 6.94 B | 6.94 B | 6.94 B | 3.8 B | 3.8 B | 3.8 B | 3.8 B | 3.24 B | 3.24 B | 3.24 B | 3.24 B | 4.14 B | 4.14 B | 4.14 B | 4.14 B | 3.73 B | 3.73 B | 3.73 B | 3.73 B | 3.8 B | 3.8 B | 3.8 B | 3.8 B | 3.26 B | 3.26 B | 3.26 B | 3.26 B | 6.95 B | 6.95 B | 6.95 B | 6.95 B |
Book Value |
90.5 B | 65.1 B | - | - | 59.2 B | 61.2 B | 65 B | 59.8 B | 62.5 B | 62.9 B | 62.9 B | 62.9 B | 62.9 B | 59.7 B | 59.7 B | 59.7 B | 59.7 B | 66.4 B | 66.4 B | 66.4 B | 66.4 B | 80 B | 80 B | 80 B | 80 B | 77.6 B | 77.6 B | 77.6 B | 77.6 B | 71.4 B | 71.4 B | 71.4 B | 71.4 B | 68.9 B | 69 B | 69 B | 69 B | 66.1 B | 66.1 B | 66.1 B | 66.1 B | 54.3 B | 54.3 B | 54.3 B | 54.3 B | 48.9 B | 48.9 B | 48.9 B | 48.9 B |
Total Shareholders Equity |
7.66 B | 3.66 B | 3.65 B | - | 916 M | 6.7 B | 8.22 B | 8.25 B | 9.33 B | 9.41 B | 9.41 B | 9.41 B | 9.41 B | 9.67 B | 9.67 B | 9.67 B | 9.67 B | 12.5 B | 12.5 B | 12.5 B | 12.5 B | 25.2 B | 25.2 B | 25.2 B | 25.2 B | 29.9 B | 29.9 B | 29.9 B | 29.9 B | 28.1 B | 28.1 B | 28.1 B | 28.1 B | 25.8 B | 25.8 B | 25.8 B | 25.8 B | 22.1 B | 22.1 B | 22.1 B | 22.1 B | 19.1 B | 19.1 B | 19.1 B | 19.1 B | 19 B | 19 B | 19 B | 19 B |
All numbers in USD currency